Susan Manzi is a Rheumatology/Immunology physician affiliated with Allegheny Health Network. OpenAlex indexes 266 publications with 21,579 citations (h-index 64). By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4815 Liberty Ave Ste 250
Pittsburgh, PA 15224
Telephone
412-578-1152Registry record last updated 21 Jun 2018.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202512 payments$13,446openpaymentsdata.cms.gov ↗
- Autolus IncProgram year20252 payments
- AstraZeneca UK LimitedProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
33.2%Corticosteroid33.2%Prednisone100%Part D≥27 patientsAntiparasitic
28.4%Antimalarial28.4%Hydroxychloroquine Sulfate100%Part D≥28 patientsNervous system
23.9%Gabapentinoids14.2%Gabapentin66%Pregabalin34%Part D<11 patientsNonsteroidal Anti-inflammatory Drug4.9%Meloxicam100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1990–2011 per NIH RePORTER. The latest:
- Vascular Disease in Systemic Lupus Erythematosus
Allegheny-Singer Research Institute
FY2011$148,824K24AR002213 - Progression of Cardiovascular Disease in Lupus.
Allegheny-Singer Research Institute
FY2010$414,302R01AR046588 - Vascular Disease in Systemic Lupus Erythematosus
Allegheny-Singer Research Institute
FY2010$148,824K24AR002213
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
Chen Xu
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”